-
New video on EMA’s work with civil societyCommittee |Regulatory
New video on EMA’s work with civil society
-
New video on EMA’s work with civil societyCommittee |Regulatory
New video on EMA’s work with civil society
Watch a video explaining how EMA enables patients, consumers and healthcare professionals to contribute to the regulatory process of medicines in the EU.
-
How EMA responded to COVID-19COVID-19 |Crisis response
How EMA responded to COVID-19
-
How EMA responded to COVID-19COVID-19 |Crisis response
How EMA responded to COVID-19
EMA shares the reflections of its late former Deputy Executive Director Noël Wathion on the measures taken by EMA to fight against the COVID-19 pandemic.
-
Communication Perception Survey 2022Survey |Communications
Communication Perception Survey 2022
-
Communication Perception Survey 2022Survey |Communications
Communication Perception Survey 2022
The results of the 4th survey conducted among EMA audiences to gather their feedback on how the Agency communicates have just been published.
-
Use of artificial intelligence in medicines’ lifecycleArtificial intelligence |Regulatory
Use of artificial intelligence in medicines’ lifecycle
-
Use of artificial intelligence in medicines’ lifecycleArtificial intelligence |Regulatory
Use of artificial intelligence in medicines’ lifecycle
Draft reflection paper for public consultation on regulators’ views on artificial intelligence for the development, use and regulation of human and veterinary medicines
Latest news
-
List item16/08/2023
EMA review of data on paternal exposure to valproate
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing data on the potential risk of neurodevelopmental disorders (NDDs) in children conceived by fathers taking valproate medicines. The review is focussing on data from a retrospective...
-
List item14/08/2023
EMA mourns passing of Noël Wathion
The European Medicines Agency announces with deep sadness the death of Noël Wathion, its former Deputy Executive Director, on 12 August 2023. Our most profound sympathies and condolences go to Noël’s family and friends. He was 66 and leaves behind...
-
List item11/08/2023 COVID-19
EMA business hours over Assumption Day, 15 August
The European Medicines Agency's (EMA) office is closed on Tuesday 15 August 2023. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600. Please note that this is an emergency...
-
List item25/07/2023
Paving the way towards coordinated clinical trials in public health emergencies in the EU
EMA has published a report from a workshop that collected insights and suggestions for possible EU-level actions to improve the way clinical trials are set up and conducted in the European Union (EU) during public health emergencies . The actions...
-
List item21/07/2023 COVID-19
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2023
14 new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its July 2023 meeting. The CHMP recommended granting a marketing authorisation for Abrysvo (bivalent, recombinant), a vaccine...
-
List item21/07/2023
First RSV vaccine to protect infants up to 6 months of age and older adults
EMA has recommended granting a marketing authorisation in the European Union (EU) for Abrysvo , a vaccine to protect against disease caused by the respiratory syncytial virus (RSV). Abrysvo is the first RSV vaccine indicated for passive immunisation...
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal